Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Genix Pharmaceuticals Corporation
  6. Financials
    GENX   CA37232A1093

GENIX PHARMACEUTICALS CORPORATION

(GENX)
Delayed Bourse de Toronto  -  05/18 11:32:34 am EDT
0.1400 CAD    0.00%
04/27GENIX PHARMACEUTICALS : - Form of Proxy
PU
04/27GENIX PHARMACEUTICALS : - Notice and Information Circular
PU
03/25Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2022
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: October 2016 2017 2018 2019 2020 2021
Capitalization1 1,501,132,442,639,808,88
Enterprise Value (EV)1 1,391,022,372,629,128,79
P/E ratio -10,3x-4,63x18,2x-15,9x-11,5x-5,38x
Yield ------
Capitalization / Revenue 1,62x2,67x5,81x19,1x--
EV / Revenue 1,50x2,43x5,64x19,0x--
EV / EBITDA -14,8x-17,9x-98,9x-21,3x-28,7x-8,05x
Price to Book 4,07x9,31x19,9x-62,3x2,01x2,21x
Nbr of stocks (in thousands) 37 51437 51437 51437 51459 40959 224
Reference price (CAD) 0,040,030,070,070,170,15
Announcement Date 02/28/201803/01/201902/27/202003/01/202102/28/202202/28/2022
1 CAD in Million
Income Statement Evolution (Annual data)
Fiscal Period: October 2016 2017 2018 2019 2020 2021
Net sales1 0,920,420,420,14--
EBITDA1 -0,09-0,06-0,02-0,12-0,32-1,09
Operating profit (EBIT)1 -0,14-0,06-0,02-0,12-0,68-1,61
Operating Margin -15,1%-13,6%-5,73%-89,7%--
Pre-Tax Profit (EBT)1 -0,15-0,03-0,03-0,16-0,72-1,65
Net income1 -0,15-0,240,13-0,16-0,72-1,65
Net margin -15,7%-57,7%31,9%-120%--
EPS2 0,00-0,010,000,00-0,01-0,03
Dividend per Share ------
Announcement Date 02/28/201803/01/201902/27/202003/01/202102/28/202202/28/2022
1 CAD in Million
2 CAD
Balance Sheet Analysis
Fiscal Period: October 2016 2017 2018 2019 2020 2021
Net Debt1 ------
Net Cash position1 0,110,100,070,010,680,09
Leverage (Debt / EBITDA) 1,19x1,76x2,92x0,09x2,15x0,08x
Free Cash Flow1 -0,100,15-0,150,030,290,68
ROE (Net Profit / Equities) -33,1%-12,4%-20,7%-410%-29,8%-37,3%
Shareholders' equity1 0,441,97-0,650,042,414,44
ROA (Net Profit / Asset) -16,3%-8,50%-4,81%-56,6%-15,7%-20,0%
Assets1 0,892,86-2,790,294,568,28
Book Value Per Share2 0,010,000,000,000,080,07
Cash Flow per Share2 0,000,000,000,000,010,00
Capex ------
Capex / Sales ------
Announcement Date 02/28/201803/01/201902/27/202003/01/202102/28/202202/28/2022
1 CAD in Million
2 CAD
Key data
Capitalization (CAD) 8 291 378
Capitalization (USD) 6 456 806
Free-Float 55,5%
Free-Float capitalization (CAD) 4 600 261
Free-Float capitalization (USD) 3 582 395
Avg. Exchange 20 sessions () 340
Avg. Exchange 20 sessions (USD) 0,00
Average Daily Capital Traded 0,00%
EPS & Dividend